CD138 Expression Helps Distinguishing Waldenström's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL)

Waldenstrom, 1944, Incipient myelomatosis or “essential” hyperglobulinemia with fibrinopenia – a new syndrome, Acta Med Scand, 117, 216, 10.1111/j.0954-6820.1944.tb03955.x Hicks, 1956, Follicular lymphoma: a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases, Cancer, 9, 792, 10.1002/1097-0142(195607/08)9:4<792::AID-CNCR2820090429>3.0.CO;2-B Harris, 1994, A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group, Blood, 84, 1361, 10.1182/blood.V84.5.1361.1361 Harris, 1999, World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House Virginia, J Clin Oncol, 84, 3835, 10.1200/JCO.1999.17.12.3835 Pangalis, 2005, Differential diagnosis Of Waldenstrom's macroglobulinemia and other B-cell disorders, Clin Lymphoma, 5, 235, 10.3816/CLM.2005.n.006 Lin, 2005, Lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia. An evolving concept, Adv Anat Pathol, 12, 246, 10.1097/01.pap.0000184176.65919.17 Owen, 2003, Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia, Semin Oncol, 30, 110, 10.1053/sonc.2003.50082 Swerdlow, 2008, Lymphoplasmacytic lymphoma, 194 Simon, 1990, Sensitivity, specificity and predictive valuey Wijdenes, 1996, A plasmocyte selective monoclonal antiboby (B-B4) recognizes syndecan-1, Br J Haematol, 94, 318, 10.1046/j.1365-2141.1996.d01-1811.x Sanderson, 1989, B lymphocytes express and lose syndecan at specific stages of differentiation, Cell Regulation, 1, 27, 10.1091/mbc.1.1.27 Sanderson, 1992, Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by the integral membrane proteoglycan, syndecan, Journal of Immunology, 148, 3902, 10.4049/jimmunol.148.12.3902 Carey, 1997, Syndecans: multifunctional cell-surface co-receptors, Biochemical Journal, 327, 1, 10.1042/bj3270001 Sebestyén, 1999, Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas, Br J Haematol, 104, 412, 10.1046/j.1365-2141.1999.01211.x Kyrtsonis, 2004, Serum syndecan-1, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and osteoprotegerin (OPG) in myeloma (MM) patients, European J Haematol, 72, 252, 10.1046/j.0902-4441.2003.00205.x Kyrtsonis, 2007, Serum soluble syndecan-1 is increased in WM/LPL and SMZL, Haematologica/The Hematology Journal, 92, 223 Owen, 2001, Waldenstrom's macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors, Am J Clin Pathol, 116, 420, 10.1309/4LCN-JMPG-5U71-UWQB Liu, 2010, Clinicopathologic features of lymphoplasmacytic lymphoma, Zhonghua Bing Li Xue Za Zhi, 39, 308 Naushad, 2009, Mantle Cell Lymphoma with Flow Cytometric Evidence of Clonal Plasmacytic Differentiation: A Case Report, Clinical Cytometry, 76B, 218, 10.1002/cyto.b.20463 Bataille, 2006, The phenotype of normal, reactive and malignant plasma cells. Identification of “many and multiple myelomas” and of new targets for myeloma therapy, Haematologica, 91, 1234 Morice, 2009, Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia, Modern Pathology, 22, 807, 10.1038/modpathol.2009.34 San Miguel, 2003, Immunophenotypic analysis of Waldenstrom's macroglobulinemia, Semin Oncol, 30, 187, 10.1053/sonc.2003.50074 deTute R. Development of specific phenotyping. Proceeding of the 6th International Workshop on Waldenstrom's macroglobulinemia. Venice, Italy; October 10, 2010. Morice WG. Novel immunophenotypic features of Waldenstrom's macroglobulinemia. Proceeding of the 6th International Workshop on Waldenstrom's macroglobulinemia. Venice, Italy; October 10, 2010. Kyrtsonis, 2001, Waldenstrom's macroglobulinemia: Clinical course and prognostic factors in 60 patients. Experience From a Single Haematology Unit, Ann Haematol, 80, 722, 10.1007/s00277-001-0385-8